Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

Warfarin vs DOACs: What’s the best indicator for a switch?

Optimal candidates for a switch from vitamin K antagonists like warfarin to direct oral anticoagulants (DOACs) have long been identified by a single statistic—time-in-therapeutic range—but a recent Danish analysis of anticoagulants in atrial fibrillation patients suggests the marker might be less insightful than previously thought.

Thumbnail

PK Papyrus covered stent gains FDA approval to treat coronary perforations

The FDA has approved the PK Papyrus covered coronary stent system to treat acute coronary artery perforations, device maker Biotronik announced Sept. 14. It is the first device to be approved by the FDA for this indication in 17 years.

Thumbnail

Angiographic completeness of PCI not tied to outcomes after FFR-guided stenting

Visual estimations of the completeness of revascularization failed to predict subsequent cardiovascular events for patients with acute coronary syndromes (ACS) who underwent stenting guided by fractional flow reserve (FFR), researchers reported in the Journal of the American College of Cardiology.

Thumbnail

AHA tightens criteria for diagnosis of resistant hypertension

The American Heart Association has tightened its guidelines for diagnosing resistant hypertension—a condition that affects up to 15 percent of patients treated for high blood pressure—according to a scientific statement published this month.

Thumbnail

Hypertension identified as risk factor for aortic valve disease

Sustained elevated blood pressure can increase a patient’s risk for both aortic valve stenosis and aortic regurgitation, according to an analysis of 5.4 million non-CVD patients in the U.K.

Thumbnail

Wearable ultrasound patch can monitor BP 4 cm below skin

Scientists have developed a wearable ultrasound device to measure central blood pressure (BP). It performed as well as a current noninvasive technique upon testing, according to a press release.

‘Reassuring’ news: Tainted valsartan didn’t increase short-term cancer risk

Carcinogen-containing valsartan products that were recalled in about two dozen countries over the past few months didn’t significantly raise cancer risk in the short term, according to a Danish registry study published online Sept. 12 in The BMJ.

Thumbnail

How diabetics can prepare for Hurricane Florence

As extreme weather hits the East Coast this weekend, residents are stocking up on nonperishables, buying batteries in bulk and boarding up windows. But storm preparation looks a little different for diabetics, who are forced to consider their medical needs weeks in advance, Everyday Health reports.